# IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya

> **NCT04898699** · EARLY_PHASE1 · COMPLETED · sponsor: **Columbia University** · enrollment: 120 (actual)

## Conditions studied

- HIV

## Interventions

- **DEVICE:** UrSure Rapid Urine Tenofovir Test
- **DEVICE:** OraQuick Rapid HIV Self-test kit
- **DRUG:** Tenofovir (300mg)/Emtricitabine(200mg) [Truvada®]
- **BEHAVIORAL:** 2-way text message reminders
- **BEHAVIORAL:** HIV risk-reduction counseling

## Key facts

- **NCT ID:** NCT04898699
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-24
- **Primary completion:** 2022-07-19
- **Final completion:** 2022-07-19
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898699, "IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04898699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*